{"title":"儿童程序性镇静和镇痛药物:系统回顾和荟萃分析。","authors":"Sandrella Hamdan, Samuel Adelou, Sébastien Jungo, Hadrien Diakonoff, Jean-Marc Treluyer, Hélène Fron Chabouis, Violaine Smail-Faugeron","doi":"10.1007/s40268-025-00522-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Performing medical procedures on children can often be challenging because of the anxiety that these procedures may induce, the need for immobility that they may require, or age-related development capabilities. We assessed the effects of procedural sedation and analgesia drugs for anxiety management in children during medical procedures.</p><p><strong>Methods: </strong>We searched PubMed Medline, Cochrane Library, American Academy of Pediatrics, Cumulative Index to Nursing and Allied Health Literature, ClinicalTrials.gov, and references of eligible studies. We included parallel-arm randomized controlled trials comparing different active drugs of procedural sedation and analgesia in children undergoing diagnostic or therapeutic, painful or nonpainful procedures. Two authors independently screened titles/abstracts, reviewed full-texts, and extracted data related to study characteristics, methodology, participants, and results. Meta-analyses involved the Mantel-Haenszel random-effects approach.</p><p><strong>Results: </strong>We included 98 studies (9161 children) in the qualitative analysis and 50 in the quantitative analysis. The probability of successful sedation rate was associated with dexmedetomidine versus midazolam alone (odds ratio [OR] 7.42, 95% confidence interval [CI] 4.08-13.48) and with midazolam and ketamine combined versus midazolam alone (OR 3.0, 95% CI 1.67-5.39). The probability of successful sedation rate was associated with dexmedetomidine 2 μg/kg versus 1 μg/kg (OR 5.21, 95% CI 1.90-14.27).</p><p><strong>Conclusions: </strong>Dexmedetomidine, and the combination of midazolam and ketamine, seem interesting for sedating children during medical procedures.</p>","PeriodicalId":49258,"journal":{"name":"Drugs in Research & Development","volume":" ","pages":"179-193"},"PeriodicalIF":2.1000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12460213/pdf/","citationCount":"0","resultStr":"{\"title\":\"Drugs for Procedural Sedation and Analgesia in Children: A Systematic Review and Meta-analysis.\",\"authors\":\"Sandrella Hamdan, Samuel Adelou, Sébastien Jungo, Hadrien Diakonoff, Jean-Marc Treluyer, Hélène Fron Chabouis, Violaine Smail-Faugeron\",\"doi\":\"10.1007/s40268-025-00522-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>Performing medical procedures on children can often be challenging because of the anxiety that these procedures may induce, the need for immobility that they may require, or age-related development capabilities. We assessed the effects of procedural sedation and analgesia drugs for anxiety management in children during medical procedures.</p><p><strong>Methods: </strong>We searched PubMed Medline, Cochrane Library, American Academy of Pediatrics, Cumulative Index to Nursing and Allied Health Literature, ClinicalTrials.gov, and references of eligible studies. We included parallel-arm randomized controlled trials comparing different active drugs of procedural sedation and analgesia in children undergoing diagnostic or therapeutic, painful or nonpainful procedures. Two authors independently screened titles/abstracts, reviewed full-texts, and extracted data related to study characteristics, methodology, participants, and results. Meta-analyses involved the Mantel-Haenszel random-effects approach.</p><p><strong>Results: </strong>We included 98 studies (9161 children) in the qualitative analysis and 50 in the quantitative analysis. The probability of successful sedation rate was associated with dexmedetomidine versus midazolam alone (odds ratio [OR] 7.42, 95% confidence interval [CI] 4.08-13.48) and with midazolam and ketamine combined versus midazolam alone (OR 3.0, 95% CI 1.67-5.39). The probability of successful sedation rate was associated with dexmedetomidine 2 μg/kg versus 1 μg/kg (OR 5.21, 95% CI 1.90-14.27).</p><p><strong>Conclusions: </strong>Dexmedetomidine, and the combination of midazolam and ketamine, seem interesting for sedating children during medical procedures.</p>\",\"PeriodicalId\":49258,\"journal\":{\"name\":\"Drugs in Research & Development\",\"volume\":\" \",\"pages\":\"179-193\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12460213/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drugs in Research & Development\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s40268-025-00522-9\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/13 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs in Research & Development","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40268-025-00522-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/13 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
摘要
背景和目的:对儿童实施医疗程序往往具有挑战性,因为这些程序可能引起焦虑,可能需要不动,或与年龄相关的发展能力。我们评估了程序镇静和镇痛药物对医疗过程中儿童焦虑管理的影响。方法:检索PubMed Medline、Cochrane图书馆、美国儿科学会、护理与相关健康文献累积索引、ClinicalTrials.gov以及符合条件的研究参考文献。我们纳入了平行组随机对照试验,比较了在接受诊断性或治疗性、疼痛性或非疼痛性手术的儿童中不同的程序性镇静和镇痛活性药物。两位作者独立筛选标题/摘要,审查全文,并提取与研究特征、方法、参与者和结果相关的数据。meta分析采用了Mantel-Haenszel随机效应方法。结果:定性分析纳入98项研究(9161名儿童),定量分析纳入50项研究。成功镇静率的概率与右美托咪定与单独咪达唑仑相关(优势比[OR] 7.42, 95%可信区间[CI] 4.08-13.48),与咪达唑仑和氯胺酮联合使用与单独咪达唑仑相关(OR 3.0, 95% CI 1.67-5.39)。右美托咪定2 μg/kg与1 μg/kg镇静成功率相关(OR 5.21, 95% CI 1.90-14.27)。结论:右美托咪定,以及咪达唑仑和氯胺酮的组合,在医疗过程中用于镇静儿童似乎很有趣。
Drugs for Procedural Sedation and Analgesia in Children: A Systematic Review and Meta-analysis.
Background and objectives: Performing medical procedures on children can often be challenging because of the anxiety that these procedures may induce, the need for immobility that they may require, or age-related development capabilities. We assessed the effects of procedural sedation and analgesia drugs for anxiety management in children during medical procedures.
Methods: We searched PubMed Medline, Cochrane Library, American Academy of Pediatrics, Cumulative Index to Nursing and Allied Health Literature, ClinicalTrials.gov, and references of eligible studies. We included parallel-arm randomized controlled trials comparing different active drugs of procedural sedation and analgesia in children undergoing diagnostic or therapeutic, painful or nonpainful procedures. Two authors independently screened titles/abstracts, reviewed full-texts, and extracted data related to study characteristics, methodology, participants, and results. Meta-analyses involved the Mantel-Haenszel random-effects approach.
Results: We included 98 studies (9161 children) in the qualitative analysis and 50 in the quantitative analysis. The probability of successful sedation rate was associated with dexmedetomidine versus midazolam alone (odds ratio [OR] 7.42, 95% confidence interval [CI] 4.08-13.48) and with midazolam and ketamine combined versus midazolam alone (OR 3.0, 95% CI 1.67-5.39). The probability of successful sedation rate was associated with dexmedetomidine 2 μg/kg versus 1 μg/kg (OR 5.21, 95% CI 1.90-14.27).
Conclusions: Dexmedetomidine, and the combination of midazolam and ketamine, seem interesting for sedating children during medical procedures.
期刊介绍:
Drugs in R&D is an international, peer reviewed, open access, online only journal, and provides timely information from all phases of drug research and development that will inform clinical practice. Healthcare decision makers are thus provided with knowledge about the developing place of a drug in therapy.
The Journal includes:
Clinical research on new and established drugs;
Preclinical research of direct relevance to clinical drug development;
Short communications and case study reports that meet the above criteria will also be considered;
Reviews may also be considered.